US 10968231
Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders
granted A61PA61P3/00A61P3/10
Quick answer
US patent 10968231 (Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders) held by Takeda Pharmaceutical Company Limited expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P3/00, A61P3/10